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Blood  monocytes,  macrophages,  and  other  cells  of the  mononuclear  phagocytic 
system perform critical  functions  in  inflammation  and  immunity.  A  large body of 
data has accumulated in recent years indicating that certain plasma proteins or their 
cleavage  fragments  can  regulate  mononuclear  phagocytic  cell  function  (1).  For 
example, macrophages are involved in phagocytic recognition via plasma membrane 
receptors for the Fc region of IgG and for cleaved C3 (2); they show oriented migration 
when chemotactic agents such as C5a and fibrinopeptides are generated (3), and they 
respond with rapid spreading and  inhibition  of migration when exposed to the Bb 
fragment derived from factor B of the alternative pathway of complement fixation, or 
when the contact phase of blood coagulation is activated (4). These proteins probably 
participate  directly  in  in  vivo events  triggered  by tissue  injury,  particularly  those 
involving accumulation of macrophages at the injury site and the clearance of debris 
that occurs before tissue reconstruction (1). 
Considerable  interest  has  developed  in  another  plasma  protein,  cold-insoluble 
globulin  (CIg, plasma fibronectin) I and the nature of its interaction with phagocytic 
cells. This giycoprotein is present  in substantial  amounts  (300  :l:  100 #g/ml,  [5])  in 
human  plasma.  The  most  common  form  in  blood  is  a  dimer  (mol  wt  450,000) 
composed of two disulfide linked chains of approximately equal size (6).  Structurally 
and  immunologically  related  forms  of fibronectin  are  found  on  cell  surfaces,  in 
basement  membranes, in  intercellular  matrices, and  in  extravascular fluids  (7-10). 
Although certain differences among them have been described (7, 8,  11), all forms of 
fibronectin  have binding sites for collagen  (12),  fibrin(ogen)  (13,  14),  heparin  (15), 
and  fibroblasts  (7-10,  16).  The  avidity  of binding  between  CIg  and  collagen  is 
enhanced by denaturation of the collagen (17,  18). In addition, CIg binds fibrin with 
higher avidity than it binds fibrinogen (14). 
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The present investigation focuses on the role that CIg plays in regulating monocyte 
function. The ability of CIg to bind substances that are likely to be present at sites of 
tissue injury (e.g., collagen and fibrin) led to the hypothesis that this protein is directly 
involved  in  regulation  of  cellular  behavior  in  the  inflammatory  response.  This 
hypothesis  is  supported  by  the  investigations  of  Blumenstock  et  al.,  who  have 
demonstrated  the  identity  between  CIg  and  a  serum  protein  termed  a-2-opsonic 
glycoprotein (19). This protein had previously been shown to promote the uptake of 
a  gelatin-coated  emulsion  by rat  liver  slices,  suggesting an  interaction  with  macro- 
phages  (20, 21). 
In this report we provide evidence that human peripheral blood monocytes possess 
a  trypsin-sensitive  plasma  membrane  receptor  for  surface-bound  CIg.  Binding  of 
monocytes to CIg leads to enhanced functional expression of their plasma membrane 
receptors for the Fc portion of IgG and for the third component of complement. Based 
upon these results we hypothesize that CIg acts as a circulating probe for fibrin or for 
exposed or altered collagen at sites of tissue damage. Binding of CIg at sites of injury 
via fibrin or collagen affinity promotes monocyte retention and subsequent enhance- 
ment of their phagocytic capacity. 
Materials  and Methods 
Preparation of Plasma and Serum.  Human blood was collected by venipuncture into sodium 
heparin  (131 USP  U/mg,  grade II; Sigma Chemical  Co.,  St.  Louis, Mo.).  The  final  blood 
concentration of heparin was 5 USP U/ml. Platelet-poor plasma was prepared frola this blood 
by centrifugation  for 5  min  at  8,700 g  (Microfuge;  Beckman  Instruments,  Inc.,  Fullerton, 
Calif.).  Human serum was obtained from whole blood, which had been incubated at 37°C for 
1 h  (a temperature that minimizes the incorporation of CIg into the fibrin clot [13]) and then 
centrifuged at  8,700 g for 5 min.  Plasma or serum was used  fresh  or stored at  --20°C. CIg- 
depleted plasma or serum was prepared by twice incubating the plasma or serum for a 30-min 
period with gelatin-Sepharose beads (12) (10 ml plasma or serum per 2.5-ml  beads)  in an ice 
bath,  after which the beads were pelleted  by centrifugation.  CIg levels  were determined by 
electroimmunoassay using a rabbit antiserum to human CIg (5). For certain experiments serum 
or CIg-depleted serum  were  heated  at  56°C  for  1 h  to inactivate  the complement  system. 
Sterilization of serum or plasma specimens by filtration through 0.45-#m Nalgene filters  (Nalge 
Co.,  Nalgene  Labware  Div.,  Rochester,  N.  Y.)  was carried  out  for those  experiments  that 
involved long-term culture periods. 
Serum  from  a  patient  (M.W.)  with  acquired  severe  hypogammaglobulineniia  had  the 
following levels of immunoglobulins: IgG, 0.24 mg/ml (normal, 8-18 mg/ml); IgM, 0.4 mg/ml 
(normal, 0.6-2.5  mg/ml);  IgA, 0.1  mg/ml  (normal, 0.9-4.5  mg/ml).  The compiement level 
(CH50) was within normal limits,  as was the immunoassayable level of CIg (0.226 mg/ml). 
CIg Preparations.  Purified human CIg was prepared by one of the following two methods: 
(a)  a  modification  (22) of the  glycine precipitation  method  of Mosesson  and  Umfleet  (5). 
Among the steps  in  this  procedure  are  included  ethanol  fractionation  and  DEAE-celluiose 
chromatography. (b) A more recent preparative procedure (D. L. Armani and M. W. Mosesson. 
Manuscript  in  preparation.)  takes  advantage  of the  fact  that  in  the cold,  heparin  induces 
precipitation  of CIg (14). CIg in the heparin  precipitate was separated  from fibrinogen, the 
only major protein contaminant, by stepwise elution from DEAE-cellulose with chaotropic salts 
(i.e., 0.3 M  KSGN in 0.1 M Tris-HCl buffer, pH 7.5). 
For separation of species of CIg differing in size (i.e., dimeric, zone I vs. monomeric, zones II 
and III) (23; D. L. Amrani and M. W. Mosesson.  Manuscript in preparation.), CIg prepared 
by either method was further fractionated on Sepharose 6B-CL, using recycling chromatography 
in the presence of 0.01 M Tris-HCl buffer, pH 8, containing 0.5 M KSCN. All relevant fractions 
were ultimately dialyzed against a 0.25 M Tris-PO4 buffer, pH 7.0, and stored at -20°C. For 
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buffered saline (PBS),  (obtained as a  10 times stock concentrate from Grand Island Biological 
Co., Grand Island, N. Y.), and maintained at 4°C. 
Blood Cell Preparations.  Normal human blood was collected by venipuncture into solutions 
containing EDTA (Sigma Chemical Co.) at a  final concentration of 10 mM. The pH of the 
EDTA solution had been adjusted to 7.4 with NaOH. The blood mononuclear cell fraction was 
isolated  from  this  material  by  centrifugation  in  a  Hypaque  (Hypaque-M,  75%  solution; 
Winthrop  Laboratories,  New  York)-Ficoll  (Ficoil  400;  Pharmacia  Fine  Chemicals,  Div.  of 
Pharmacia Inc., Piscataway, N. J.) solution (density 1.078 g/ml) as described by Boyum (24). 
The mononuclear cell layer accumulating at the interface of the plasma and Hypaque-Ficoll 
solution was washed several times by centrifugation at 200 g for 10 min after resuspension in 
EDTA (5 mM)-Hanks' balanced salt solution (once), with Hanks' balanced salt solution alone 
(twice),  and finally with Dulbecco's modified Eagle's medium (MEM). Frequently, the mono- 
nuclear cell fraction suspended in Dulbeceo's MEM was centrifuged at low speed (100 g for 10 
rain)  to remove platelets.  Hanks' balanced salt solution without calcium or magnesium and 
Dulbecco's  MEM  were  obtained  from  Grand  Island  Biological  Co.,  as  a  10  times  liquid 
concentrate and in powdered form, respectively. For some experiments leukocyte-rich plasma, 
also containing a substantial  number of erythrocytes, was prepared by sedimentation  at  I g. 
Polymorphonuclear leukocyte-rich cell  fractions were prepared as described by Cramer et al. 
(25) using human venous blood anticoagulated with EDTA. 
Cell Binding  to Gelatin- or Collagen-coated Surfaces (the Monocyte Binding Assay) 
The assay to evaluate and to quantify attachment  of cells to gelatin- or collagen- 
coated surfaces involved several distinct steps:  (a)  preparation of gelatin- or collagen- 
coated  surfaces;  (b)  incubation  of these  surfaces  with  plasma  or serum  proteins;  (c) 
incubation of surfaces with blood cells;  (d) determination  of the type and number of 
attached cells. Details are given below. 
PREPARATION  OF  GELATIN- OR  COLLAGEN-COATED SURFACES.  Acid-soluble collagen 
surfaces were prepared essentially as described by Klebe (26) using acid-soluble bovine 
tendon  collagen  (catalogue  number  3511;  Sigma  Chemical  Co.),  which  had  been 
dissolved in 2% acetic acid by stirring overnight at 4°C. The bottom of each well (16 
mm  Diam)  of a  plastic  tissue  culture  plate  (24  wells/plate;  Linbro  Chemical  Co., 
Hamden,  Conn.)  was  coated  with  approximately  0.05  ml  of the  collagen  solution. 
These  solutions  were  exposed  to  NHaOH  fumes  for  10  min  to  allow  gelation  of 
collagen and then dried overnight at room temperature.  The dried surfaces were then 
washed  with  0.1%  NH4OH  followed  by several  washes  with  distilled  H20.  Subse- 
quently,  they were  exposed  to 5  M  urea  for  15  min  at  room  temperature,  washed 
several times with distilled  H20, and air-dried. 
Gelatin-coated surfaces were prepared by adding 0.5 ml of a  solution of 30 mg/ml 
gelatin  (catalogue number 6-2625,  Sigma Chemical Co.)  in water  to each well of a 
Linbro  tissue  culture  plate  followed  by  incubation  at  37°C  for  2  h.  The  gelatin 
solution was removed by aspiration,  and the plate was dried  for 2 h  at 40°C. These 
plates were stored at room temperature.  The uniformity of the acid-soluble collagen 
surfaces  or the  gelatin  surfaces  was  assessed  by staining  randomly selected  sample 
wells with Coomassie brilliant  blue (0.2 mg/ml in methanol-acetic acid solution). 
INCUBATION  OF  COLLAGEN-  OR  GELATIN-COATED SURFACES  WITH  PLASMA  OR  SERUM 
PROTEINS.  Heparinized  plasma,  serum,  CIg-depleted  plasma  or serum,  or purified 
human plasma proteins, viz., CIg, gamma globulin (Cutter Laboratories, Inc., Berke- 
ley, Calif.) or albumin (Sigma Chemical Co.) were diluted to the desired concentration 
with PBS and added in 0.5-ml portions to each well of the gelatin- or collagen-coated 
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removed by aspiration, and  the wells were washed  three times with  PBS. Controls 
included incubation of wells with PBS alone. 
INCUBATION OF  SURFACES  WITH  BLOOD  CELLS.  Mononuclear-rich cell fractions or 
polymorphonuclear-rich  cell  fractions  in  Dulbecco's  MEM  were  adjusted  to  cell 
concentrations of 2  ×  106/ml  or  2  ×  10S/ml,  respectively, and  0.5  ml  of the  cell 
suspension was added to each well of the culture plate. The gelatin-coated plates were 
then incubated for 1 h at room temperature whereas the collagen-coated plates were 
incubated  at  37°C  in  a  5%  CO2 atmosphere. At  the end of the incubation period 
nonattached cells were removed by washing the wells three times with  Dulbecco's 
MEM. 
DETERMINATION OF THE TYPE AND NUMBER OF ATTACHED CELLS.  One of two methods 
was used in counting attached cells. The first involved release of the adherent cells by 
incubation  for  15-20 min  at  room temperature in  the presence of 1 ml  of Hanks' 
balanced salt solution containing l0 mM EDTA. A bulbed pasteur pipette was used 
to agitate the  fluid in  completing the release of cells, and  the cell suspension  was 
subsequently counted in an automatic cell counter (Cytograph; Ortho Pharmaceutical 
Corp., Raritan, N. J.). 
The second method of counting entailed glutaraldehyde fixation (1.25%  glutaral- 
dehyde vol:vol, in PBS for  10 min)  of attached cells followed by direct microscopic 
counting  of five  randomly  selected  high-power  fields  (X  500)  per  well.  The  cell 
number was reported as a  function of the surface area of the well  (cells  per square 
centimeter). Comparison of these  two methods indicated that  they yielded similar 
values. 
The  cell  type  attaching  to  surfaces  was  determined  by  standard  morphologic 
criteria using plase-contrast  microscopy of live or glutaraldehyde-fixed cells, or by 
direct  light  microscopy of fixed cells  stained  with  McNeal  tetrachrome  (Harleco, 
American Hospital Supply Corp., Gibbstown, N. J.). 
Functional differentiation of attached cells types (i.e., monocytes vs. lymphocytes) 
was  made by determining  (a)  their ability to spread on surfaces  (27)  and  (b)  their 
capacity to ingest IgG-coated erythrocytes (28). 
Particle-binding Assays 
Assays for attachment and/or ingestion of indicator particles by monocytes were 
performed in the following stages:  (a) preparation of monocyte cultures; (b) prepara- 
tion of indicator particles;  (c) incubation of indicator particles with cultured mono- 
cytes; and  (d)  determination of the number and location of cell-associated particles. 
Details are given below. 
PREPARATION  OF  MONOCYTE CULTURES.  Monocytes  were  established  in  culture 
essentially following the procedure of  Johnson et al. (29). In general, the mononuclear 
cell layer obtained from the Hypaque-Ficoll procedure was suspended in Dulbecco's 
MEM  (2.0  ×  106 cells/ml)  containing either 7% heat-inactivated human  serum or 
heat-inactivated CIg-depleted human serum. The cells were incubated in the wells of 
plastic tissue culture plates for  1 h  at  37°C  in a  5% CO2 atmosphere, and then the 
wells were washed with Dulbecco's MEM to remove nonadherent cells. Adherent cells 
were maintained in Dulbecco's MEM or in the serumless medium of Newman Tytell 
(Grand Island Biological Co.) to which we added penicillin, streptomycin, fungizone, 
and human serum (2%, final concentration) or CIg-depleted serum (2%, final concen- 46  MONOCYTE  RECEPTORS  FOR  COLD-INSOLUBLE  GLOBULIN 
tration). Alternatively, monocyte cultures were established and maintained on plastic 
surfaces, which had been preincubated with CIg, or gelatin- or acid-soluble collagen- 
coated surfaces, which had been preincubated with CIg or with 50% human serum. 
Modifications of the above procedures are specified in the text. 
PREPARATION OF INDICATOR  PARTICLES.  Gelatin-coated beads were prepared  from 
polyvinyltoluene latex  beads  (2  ~m  Diam,  Dow  Chemical  Co.,  Midland,  Mich.), 
which had been washed  in  70% alcohol, followed by three washes in distilled  H20. 
Approximately 101° washed beads were suspended to  10 ml in PBS containing heat- 
liquefied gelatin (10 mg/ml). The suspension was incubated at room temperature for 
2 h  and  then stored at  4°C.  Before use,  the gelatin  was liquefied  at  37°C, and  the 
beads were washed four times by centrifugation in PBS. The final pellet was suspended 
in Dulbecco's MEM to the desired particle concentration, typically 3.0 ×  107 beads/ 
ml. 
Gelatin-coated tanned erythrocytes (TEG) were prepared from fresh sheep blood, 
which had been diluted  1:1  with Alsever's solution  (30)  and then stored at  4°C for 
periods of up to 2 wk. These erythrocytes were washed three times by centrifugation 
(250  g)  in  PBS.  Tannic  acid  (Fisher  Scientific Co.,  Pittsburgh,  Pa.)  treatment  was 
carried out as described by Rabinovitch (31), by incubation for 30 min at 37°C at an 
erythrocyte and tannic acid concentration of 1.3 ×  10S/ml  and 25 #g/ml, respectively. 
The tanned cells  were then washed twice with PBS and suspended  (2.5  X  l0  s cells/ 
ml)  in  a  gelatin(10  mg/ml)-PBS solution.  The suspension  was  incubated  at  room 
temperature for 3 h and then at 4°C for at least another 24 h. Before use, the gelatin- 
cell  suspension  was  further  processed  as  described  above  for  the  latex  beads  and 
suspended in Dulbecco's MEM to a  final concentration of 2.0 ×  107 cells/ml. 
CIg treatment  of gelatin-coated  latex  beads  and  TEG  was  as  follows.  Washed 
particle suspensions were mixed with CIg solutions in plastic tubes at a final volume 
of 1 ml. The tubes were placed on a rotary shaker and incubated for 30 min at room 
temperature in a 5% COs atmosphere. At the end of the incubation period, 0.5 ml of 
each suspension was added to duplicate wells of the culture plates. 
IgG-coated sheep erythrocytes (EIgG) or IgM and complement-coated erythrocytes 
(EIgMC) were prepared as previously described  (28) using mouse serum as a  source 
of  complement  plus  the  IgG  or  the  IgM  fraction  from  an  antiserum  to  sheep 
erythrocyte (Cordis Laboratories Inc., Miami, Fla.). These indicator erythrocytes were 
prepared on the day of use and suspended at a concentration of 1 X  l0  s cells/ml in 
Dulbecco's MEM. 
INCUBATION OF  INDICATOR PARTICLES WITH CULTURED MONOCYTES.  Before the addi- 
tion of test particle suspensions to the wells  (0.5 ml/well), the monocyte cultures were 
washed twice with Dulbecco's MEM. The particles were then added, and the plates 
were incubated at 37°C in a 5% CO2 atmosphere for periods varying from 30 min to 
3 h. At the end of this incubation the wells were washed three times with Dulbecco's 
MEM to remove nonadherent material. 
DETERMINATION  OF  THE  NUMBER  AND  LOCATION  OF  CELL-ASSOCIATED  PARTI- 
CLES.  Differentiation of surface-attached from ingested particles was accomplished 
in the following ways. In the case of erythrocytes, surface-bound particles were lysed 
by exposure of the culture to a hypotonic solution (PBS diluted  1:4 in H20) for 10 s, 
the culture fluid aspirated and fixative then added  (1.25% glutaraldehyde, vol:vol in 
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plastic surface were released by exposure to a  solution of trypsin  (100 #g/ml)  and 
EDTA  (10  mM)  in  Hanks' balanced  salt  solution for 20  min  at  37°C,  and  then 
washed three times with Dulbecco's MEM. The cells were subsequently fixed with 
glutaraldehyde. 
Particle counting was  done  in  duplicate wells using an  inverted  phase-contrast 
microscope. At least 200 monocytes from three or more randomly selected fields were 
counted per well. The data were reported as the number of particles attached to or 
ingested by 100 monocytes (attachment or ingestion index). 
Results 
Monocyte Binding to Surfaces Coated with Collagen and CIg.  Human peripheral blood 
monocytes adhere rapidly to  plastic or  glass  surfaces.  Coating such  surfaces with 
gelatin or acid-soluble  collagen abrogates  this  adherence  activity. However,  prior 
incubation of collagen-coated surface with a  source of CIg, at levels of 2.5 #g/cm  2 
surface or higher,  results  in  a  concentration-dependent increase in the number of 
monocytes that adhere (Fig. 1). Other serum proteins such as IgG or albumin, do not 
promote such binding. 
We observed some variability in the background adherence of monocytes to the 
collagen-coated surfaces. Background monGcyte adherence could be maintained at 
low  levels  (<10%  of maximum)  by  the  selection  of culture  plates  that  had  been 
carefully monitored for completeness of gelatin coating of the surfaces and by avoiding 
platelet contamination in the mononuclear cell fraction. 
The Hypaque-Ficoll system used in the preparation of mononuclear leukocytes for 
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Fro.  1.  An experiment showing binding of human peripheral blood monocytes to gelatin-coated 
surfaces, which had first been incubated with various human plasma proteins. The medium in all 
such experiments contained Ca  ++ and Mg  ++. In this type of experiment, the maximum number of 
adherent monocytes was as high as 50 ×  10a/cm  2. The number of monocytes bound is indicated on 
the  ordinate;  the  levels of protein  preincuhated  in  the  wells  are  expressed on  the  abscissa as 
micrograms per square centimeter. Determination of the amount of CIg bound to coated surfaces 
as assessed with  I-labeled CIg indicated that only a  small fraction of the added CIg (<1%)  had 
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these  experiments  yields  a  fraction  consisting  of about  20%  monocytes  and  80% 
lymphocytes. "When this fraction is incubated with CIg-collagen surfaces, only mon- 
ocytes adhere.  The evidence for this is the following:  (a)  within  30 min virtually all 
attached mononuclear cells demonstrated typical monocyte spreading and membrane 
ruffling,  as  assessed  by  phase-contrast  microscopy;  furthermore,  typical  monocyte 
morphology was observed in fixed and stained  preparations;  (b) 96% of the attached 
cells ingested two or more IgG-coated erythrocytes, thus demonstrating their viability 
and capacity for immune-mediated  phagocytosis. 
Polymorphonuclear  leukocytes  from  polymorphonuclear  leukocyte-rich  fractions 
(three experiments) showed no tendency to adhere to CIg-gelatin surfaces. In addition, 
in  similar  experiments  with  leukocyte-rich plasma,  fewer than  5%  of the  cells  that 
bound to gelatin-CIg surfaces were neutrophils,  and more than 95% were monocytes. 
The  mechanism  of attachment  of monocytes  to  CIg-collagen  surfaces  differs  in 
several  respects  from that  to plastic in that  (a)  as pointed out above, attachment  of 
monocytes to plastic surfaces does not require CIg; (b) vigorous washing of ceil cultures 
with a  pasteur pipette will readily release monocytes from a  CIg-gelatin surface but 
not from a  plastic surface;  (c) trypsin treatment releases nearly  100% of the cells from 
the  CIg-gelatin  surface  whereas  the  same  treatment  of monocytes bound  to plastic 
does not cause release but instead leads to enhanced spreading. 
The  presence  of heparin  at  levels as high  as  100 ~g/ml  or fl-mercaptoethanol  at 
levels as high as  1 mM, or both, did not modify the characteristics of attachment  of 
monocytes to CIg-gelatin surfaces. 
Divalent Cation Requirements for Monocyte Binding.  The  following experiments  were 
designed  to investigate  divalent  cation  requirements  for monocyte binding  to CIg- 
gelatin-coated surfaces (Fig. 2). Although gelatin surfaces themselves could be coated 
with  CIg in  the  absence  of divalent  cations,  monocytes did  not  adhere  to surfaces 
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FI~. 2.  The magnesium requirement for monocyte binding to CIg-gelatin surfaces. In this exper- 
iment gelatin-coated surfaces were preincubated with CIg (50/xg/cm 2 surface) and then washed 
with PBS. A mononuclear cell-rich fraction from human peripheral blood was then suspended in 
Hanks' solution containing added Mg  ++ (abscissa), and the cells were allowed to become adherent 
to  the  CIg-gelatin surface for  1 h  at  room temperature  (closed circles). Some cell suspensions 
contained Ca  ++, 1 mEq/liter,  in addition to Mg  ++ (open squares). BEVILACQUA, AMRANI, MOSESSON, AND BIANCO  49 
without divalent cations being present in the medium. (This was not true of monocyte 
attachment to plastic surfaces.) The presence of Mg  ++ in the suspension resulted in a 
concentration-dependent increase in the number of monocytes that attached to CIg- 
gelatin surfaces. Comparative experiments with Ca  ++ at relatively low concentration 
(i.e.,  up  to  2  mEq/liter)  resulted  in  modest  augmentation  of the  number  of cells 
attached  (less than one third of that observed with Mg++);  at Ca ++ concentrations 
about  2  mEq/liter toxic effects on  the cell population were observed. Mixtures of 
Mg  ÷+ and Ca  ++ resulted in significantly reduced binding relative to Mg  ++ alone. 
The cation (i.e., Mg  ÷+) dependence of monocyte attachment was also inferred from 
the  effect  of chelating  agents.  EDTA  (5  mM)  promoted  quantitative  release  of 
previously bound monocytes. EGTA (5  mM), a  chelating agent  with  much higher 
affinity for Ca ++ than for Mg  ++, had little effect on cell attachment  to CIg-gelatin 
surfaces. 
Monocytes released by EDTA (5-10 mM) were viable in that they, like previously 
unattached monocytes, readily adhered to a plastic surface and could be reattached 
to CIg-gelatin surfaces in the presence of Mg  ÷+. Furthermore, these monocytes were 
capable of ingesting IgG-coated sheep erythrocytes. Thus, reattachment of EDTA- 
released monocytes to a CIg-gelatin surface demonstrates the reversibility of the cell- 
CIg interaction. This manipulation provides a  simple method for preparing a  pure 
suspension  of  monocytes  (M.  P.  Bevilacqua,  M.  W.  Mosesson,  and  C.  Bianco. 
Manuscript in preparation.). 
Evaluation of Various Preparations of CIg.  We evaluated highly purified CIg, which 
had  been  prepared  in  the  presence of ethanol  and  glycine (5)  or which  had  been 
prepared using heparin precipitation (D. L. Amrani and M. W. Mosesson. Manuscript 
in  preparation.).  Both types of CIg preparations were comprised of ~80%  dimeric 
species (zone I, tool wt 450,000) and -20% smaller molecular weight forms (zone II, 
mol wt  190,000-235,000)  (22,  23).  Some preparations  were further subfractionated 
using molecular exclusion chromatography to separate the larger dimeric species from 
those of smaller molecular weight. 
All unsubfractionated CIg preparations (viz., containing both zones I and II species) 
were equally effective in  promoting monocyte attachment  to  gelatin  surfaces. CIg 
zone II also promoted concentration-dependent attachment ofmonocytes to a collagen 
surface, but this material was less effective than unsubfractionated material over the 
entire concentration range tested (Fig. 3). This difference was somewhat more marked 
at the lower concentrations (i.e., 12.5/~g/cm 2 surface or less). 
Serum-mediated Monocyte Attachment  to Gelatin Surfaces.  Initial  results demonstrated 
that  human  plasma  or  serum  promoted  concentration-dependent  attachment  of 
monocytes to gelatin surfaces. The role of CIg in this phenomenon was investigated 
by depletion-reconstitution experiments  (Fig.  4).  Serum  that  had  been depleted of 
CIg did not support monocyte attachment to gelatin surfaces. Reconstitution of this 
serum  with  CIg  restored  the  monocyte attachment  activity  to  a  level  that  was 
equivalent to that  of the untreated serum  or to that  of purified CIg itself. Similar 
quantitative results were obtained with heparinized plasma which had been processed 
in the same way as the serum. 
Several additional experiments were performed to exclude participation of other 
serum proteins known to interact with monocytes. Heat inactivation of serum com- 
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Flo. 4.  Results of an experiment showing CIg dependence of serum-mediated binding of human 
monocytes to gelatin surfaces. Gelatin surfaces were incubated  with the following: normal human 
serum  (+), 272 lag CIg/ml; the same serum after CIg depletion  (El); CIg-depleted  serum after 
reconstitution  with purified CIg (A); purified CIg (0). Data relating to Clg-depleted serum are 
plotted in terms of the original CIg concentration. 
the  possibility that  either  the  classical or the  alternative pathways of complement 
fixation  had  participated in  this reaction.  The  possibility that  serum-mediated at- 
tachment of monocytes could be a result of adsorption of IgG molecules to the gelatin 
surface  was  excluded by the  demonstration  that  serum  from  a  patient  with  severe 
hypogammaglobulinemia  promoted  monocyte  attachment  to  gelatin  in  a  manner 
that corresponded with its level of CIg. 
Attachment of Clg-coated Particles to Monocytes.  The capacity ofmonocytes to recognize 
collagen-bound Cig was also studied using gelatin-coated particles. Several types of 
particles were evaluated, but  gelatin-coated latex beads and TEG  proved to be the 
most useful and convenient. When such gelatin-coated particles were incubated with 
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conditions for periods of 2 h to 8 d, only small numbers of particles became attached 
(<50/100  monocytes in the case of latex particles, or <10/100  monocytes in the case 
of tanned erythrocytes). 
Preincubation  of  gelatin-coated  particles  with  CIg  promoted  a  concentration- 
dependent increase in the number of particles binding to such monocytes (Fig. 5). As 
had been the case with monocyte binding to CIg-gelatin surfaces (see Fig. 2), divalent 
cations  were  required  for CIg-dependent  particle  attachment.  Similar  results  were 
obtained (single experiment) when gelatin-coated latex beads were offered to mono- 
cytes that had first been plated on a CIg-gelatin surface. 
On the other hand, preincubation of CIg with monocyte monolayers (rather than 
with gelatin-coated particles)  followed by washing with medium to remove unbound 
material, did not result in increased gelatin-coated particle binding (Fig. 5). Further- 
more, in other experiments, preincubation of mononuclear cell suspensions with CIg 
followed by washing to remove unbound material, also did not result in augmented 
attachment of the cells to gelatin-coated surfaces. 
Fate  of Particles Attached  to  Monocytes.  It  was  important  to  determine  whether 
attached CIg-coated particles were subsequently ingested by the cells. In the case of 
latex beads, even after periods of incubation with monocyte monolayers of up to 3 h, 
the  addition  of trypsin  (100  #g/well)  and  EDTA  (5  mM)  for 20  min  reduced  the 
number of bound  particles  to background  levels, an  indication  that  interiorization 
had not taken place (data not shown). 
In the case of TEG, which had been incubated with surface-attached monocytes for 
periods of up to 3 h, hypotonic lysis also permitted a distinction between interiorized 
erythrocytes (protected from lysis, Fig. 6) from those bound to the cell surface (lysed). 
This  type of experiment  showed  that  there  had  been  no  CIg-dependent  ingestion 
regardless of the degree of particle attachment. 
Although  CIg does not  itself promote ingestion of gelatin-coated particles, it was 
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FIG. 5.  Results of an experiment in which CIg was preincubated with either monocytes  attached 
to plastic surfaces or with gelatin-coated latex beads before contact with one another. Each culture 
well ultimately received 107  beads. The  number of latex beads attaching per  100  monocytes 
(ordinate) was plotted against the amount of CIg expressed as microgram per CIg  107  beads 
(abscissa). The amount of CIg used for preincubation of monocytes is normalized to this scale. 
Background attachment (50 beads/100 monocytes) was subtracted. 52  MONOCYTE RECEPTORS FOR COLD-INSOLUBLE  GLOBULIN 
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FIG. 6.  The number of TEG associated with monocytes  before and after hypotonic lysis. In this 
experiment TEG were incubated with various  concentrations of CIg (abscissa) for 30 min and then 
incubated with monocyte  monolayers  for 3 h at 37°C. Nonadherent TEG were removed by washing, 
and all cell-associated TEG were counted (Total). The cultures were then subjected to hypotonic 
lysis for 10 s, and the TEG internalized by monocytes  were scored (Ingested). 
possible to demonstrate that CIg-mediated binding of particles to monocytes does not 
impede subsequent  particle  ingestion  induced by appropriate opsonic signals.  CIg- 
coated TEG were  first  incubated  with  monocytes for 3  h,  then  nonadherent  TEG 
were gently washed away, and the IgG fraction of an antiserum to sheep erythrocytes 
was added to some wells.  After 30 min, all wells were exposed to hypotonic lysis  for 
10 s, and  the number of internalized TEG was then  determined.  In sharp contrast 
with control wells,  almost all previously attached erythrocytes had been ingested by 
monocyte cultures to which the IgG had been added. 
Adding heparin  at  levels  of 100 ~g/ml  and/or fl-mercaptoethanol  at  levels  of 1 
mM did not modify the fate of the CIg-coated particles in this experimental system. 
Protease Susceptibility of Monocyte Binding of CIg.  The foregoing experiments indicate 
that monocytes are capable of recognizing CIg bound to collagen, presumably via a 
receptor. Proteolytic degradation of monocyte surface proteins provided information 
concerning the nature and location of the putative receptor. Preincubation of mono- 
cyte monolayers with trypsin completely prevented the subsequent  binding of latex 
beads coated with gelatin and CIg (Fig.  7) and, in addition, caused the cells to exhibit 
enhanced spreading. Chymotrypsin was only weakly effective in preventing particle 
binding. After tryptic or chymotryptic digestion the monocytes remained attached to 
the plastic surfaces, thus providing one indication of their viability. Further evidence 
of cell  viability was obtained  by the  demonstration that  trypsin- or chymotrypsin- 
treated  monocytes retained  their capacity to ingest  EIgG. Because trypsin does not 
normally penetrate the surface of viable cells  (32),  these data suggest that at least  a 
portion of the structure representing the CIg receptor faces the cell exterior and  is 
sensitive to tryptic hydrolysis. 
Effect of CIg on the Fc and C3 Receptor Activity  of Macrophages.  Several experiments 
were  carried  out  to  investigate  the  relationship  between  the  surface  on  which  a 
monocyte is  plated  and  the  expression  of its  Fc and  C3  receptors  (Figs.  8  and  9). 
Mononuclear leukocytes that  had  been  suspended  in  7%  heat-inactivated,  CIg-de- 53 
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Fro.  7.  The attachment of CIg-gelatin-coated latex beads to untreated or trypsin-treated monocyte 
cultures (200 ,u.g/well for 15 min at room temperature). Tryptic digestion was terminated by the 
addition of soybean trypsin inhibitor (200 #g/well)  followed  by several washes with Dulbecco's 
MEM. Control wells were washed in the same way. The gelatin-coated beads had been incubated 
with CIg (abscissa)  for 30 min, and subsequently were incubated with the monocyte cultures for 1 
h at 37°C. Cell-associated beads are indicated on the ordinate. 
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Fxo. 8.  Attachment and ingestion of IgG-coated erythrocytes (EIgG). Monocytes in certain wells 
were incubated for I h  in the presence of 7% CIg-depleted serum (1 h). Some of these wells were 
incubated for an additional 5 h in 2% CIg-depleted serum (6 h). After each type of incubation the 
cells were offered EIgG. The results shown reflect  data averaged from two separate experiments. 
pleted serum were allowed to attach  to plastic surfaces or to gelatin surfaces that had 
been pretreated  with CIg  (50 #g/cm2).  After  1 h  incubation,  nonadherent  cells were 
removed,  and  the monocyte  cultures were  maintained  on these surfaces  for  1 or 6  h 
before addition  of sensitized erythrocytes. 
As compared  with  monocytes  bound  to plastic surfaces  (Fig.  8),  monocytes  plated 
on  ClIg-gelatin  surfaces  bound  and  ingested  five or  more  times  the  number  of IgG- 250 - 
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Fio.  9.  Attachment  and  ingestion  of IgM-  and  complement-coated erythrocytes  (EIgMC)  by 
monocytes on plastic or CIg-gelatin surfaces. Experimental design was the same as that described 
in the preceding legend, except for the type of particle introduced. 
coated erythrocytes. Markedly enhanced Fc receptor activity was also observed when 
monocytes were plated on CIg-coated plastic surfaces (data not shown). 
C3-mediated attachment of particles (EIgMC) to human monocytes is not followed 
by ingestion (Fig. 9). The C3 receptor activity that is evident after 1-h incubation on 
plastic surfaces was virtually lost (<10%) after 6 h. Monocytes plated on CIg-coated 
plastic surfaces showed relative enhancement of C3 receptor activity at the 6-h time 
period but not at  1 h  (data not shown). Time-dependent loss of C3 receptor activity 
was not evident in the case of CIg-gelatin surfaces. Instead there was enhancement of 
this activity at both time periods. 
Augmentation of Fc and C3 receptor activity was retained after the cells had been 
released  from  the  surface  by  EDTA  treatment  and  subsequently  reattached  to  a 
plastic surface in the absence of CIg. 
Discussion 
Our  present  experiments  have  provided  insights  into  the  control  of monocyte 
behavior by the plasma  protein, CIg  (plasma  fibronectin). The data  indicate that 
human peripheral blood monocytes have plasma membrane receptors (CIgR) for this 
protein, and these receptors are not expressed on other leukocytes. Generally accepted 
criteria supporting the notion of such a receptor include: specificity of the interaction, 
ligand  concentration dependence, reversibility of binding,  receptor location on the 
plasma  membrane, and induction of cellular function after ligand-receptor interac- 
tion.  Our  evidence  for  CIgR  is  as  follows:  (a)  among  all  plasma  proteins,  the 
interaction between monocytes and collagen is mediated specifically by CIg (Figs.  1 
and  4);  (b)  attachment  of monocytes to collagen-coated surfaces and  to collagen- 
coated particles is  mediated  by CIg in  a  concentration-dependent manner  (Figs.  1 
and  5);  (c)  the receptor-ligand interaction can be reversed by manipulation  of the 
concentration  of extracellular  Mg  ++  (Fig.  2);  (d)  trypsin  treatment  of monocytes 
ablates  the  CIg-monocyte interaction  (Fig.  7);  (e)  the  expression  of other  known 
monocyte membrane receptors, namely, those for the Fc portion of IgG and for C3b 
is enhanced as a result of the CIg-monocyte interaction (Figs. 8 and 9). BEVILACQUA, AMRANI, MOSESSON, AND BIANCO  55 
Other  receptor  characteristics  such  as  saturability  and  displacement  of ligand 
binding that have been applied in evaluating peptide hormone receptors (33) cannot 
yet be studied unambiguously in the case of CIgR because CIg monocyte interactions 
are promoted only by surface-bound molecules. A similar situation has been encoun- 
tered in characterizing C3b receptors (34). 
The direct correlation between the number of monocytes bound to a CIg-collagen 
surface and the amount of CIg added to the system (Figs.  1 and 3) suggests that CIgR 
may not be expressed uniformly in the monocyte population. The uneven expression 
can be accounted for by differences in the number of CIgR population per cell, by 
the relative binding affinities among the CIgR, and/or by CIgR membrane mobility. 
Whatever the explanation, monocyte surface attachment occurs in vitro at CIg levels 
that could be expected to occur in vivo. That is, the CIg concentration above which 
measurable cell attachment occurs is at about  3% of the normal plasma level CIg 
(Fig.  1).  At  higher concentrations, still  well  below  circulating levels,  virtually all 
monocytes bind to collagen surfaces. 
The high avidity of monocytes for CIg bound to collagen compared with their lack 
of avidity for soluble CIg was evident in several types of experiments (Fig. 5 and see 
above). This behavior is analogous with that of leukocyte Fc receptors, which have a 
higher  avidity  for  multimolecular antigen  antibody complexes  than  they do  for 
paucimolecular complexes or for soluble monomolecular IgG (35). Just as has been 
postulated  for IgG,  fibronectin monocyte interaction may either require  allosteric 
changes of the fibronectin molecule or, alternatively, may be related to cooperation 
of multiple low affinity binding sites, or both. 
There  also are  parallels  between  the characteristics of CIgR and  the monocyte 
receptor  for C3b.  Both  receptors  require  Mg  ++  for activity, both  are  sensitive to 
tryptic proteolysis (36), and both mediate particle attachment but not ingestion (37). 
Despite  these  similarities,  differences  in  the  cell  types bearing  C3  receptors  (i.e., 
monocytes, B  lymphocytes, neutrophils, erythrocytes) suggest that  monocyte CIgR 
and  C3b  receptors  are  functionally distinct.  For  example,  under  our  conditions, 
neutrophils, B lymphocytes, and erythrocytes were unable to recognize and to bind to 
CIg-collagen surfaces. Although recent preliminary reports suggest that neutrophils 
do bind to CIg (38,  39),  we did not observe such an activity either in our present 
experiments or in other investigations (unpublished data)  in which CIg coating of 
plastic surfaces actually inhibited adherence of neutrophils. 
Fibronectin receptors have also been identified on fibroblasts (16). Although some 
of the features of fibroblast receptors are similar to those that we have described for 
monocyte CIgR (e.g., susceptibility to trypsin), the lack of requirement for Mg  +÷ for 
receptor-ligand interaction constitutes a major difference. 
We found that the reproducibility of data involving background cell binding in 
CIg-dependent  systems  required  mononuclear  cell  preparations  having  minimal 
platelet contamination. This finding is not surprising because platelets are known to 
contain substantial amounts of fibronectin in their a-granules (40, 41).  Upon stimu- 
lation, a  portion of this CIg is released into the surrounding medium (40, 41)  while 
some becomes inserted into the platelet membrane (41). Without further experimen- 
tation, it is difficult to assess the role that platelet fibronectin plays in modulating in 
vivo monocyte/macrophage function or for that matter the role that is played by 
fibronectin secreted by monocytes (42) or macrophages (43). 56  MONOCYTE RECEPTORS FOR COLD-INSOLUBLE GLOBULIN 
It will be informative to study the monocyte binding activity of matrix forms of 
fibronectin such as those produced by fibroblasts or those found in basement mem- 
branes (reviwed in references 7-10). One previous report (44) showed that substrate- 
bound microexudate produced by baby hamster kidney (BHK) cells in culture was 
an excellent surface for plating human monocytes. Furthermore, these attached cells 
could be released by adding EDTA to the system. Although the exact nature of the 
attachment was not investigated, the fact that fibronectin is a  major component of 
the BHK microexudate is consistent with the idea that  matrix forms of fibronectin 
can support monocyte adherence. 
Interaction between CIg-collagen surfaces or particles and monocytes leads to the 
two following significant events: (a) attachment of monocytes to the collagen surfaces 
or particles, and (b) enhancement of the expression of cell receptors for Fc and for C3. 
These phenomena relating to CIg-mediated monocyte attachment may be physiolog- 
ically significant. That is, CIg may behave as a circulating probe for tissue damage by 
virtue of its capacity for recognizing fibrin and denatured collagen. Such interactions 
may be a determinant of monocyte retention at sites of injury. 
Our  finding  that  CIg  does  not  mediate  particle ingestion  is  consistent  with  the 
observation of Molnar et  al.  (45)  on  particle  release from trypsin-treated rat  liver 
slices,  and  deserves special discussion.  Most previous experimental systems used for 
assessing  mononuclear phagocyte-CIg interactions  did  not  address  the  question of 
attachment  vs.  ingestion  (19-21, 45-47).  Opsonins,  as first defined by Wright  and 
Douglas  (48), promote phagocytosis, and this process involves both attachment and 
ingestion  (49).  Thus, although some investigators have classified CIg as an opsonic 
protein, our evidence indicates that CIg is not a complete opsonin. Nevertheless, it is 
possible that CIgR behave like C3b receptors on mouse macrophages, which them- 
selves are able to mediate ingestion only at specific stages of cell differentiation (50). 
CIg, like C3b, may also participate in phagocytosis by increasing the contact between 
the cell and the phagocytic target. 
As compared with the liver slice assay, neither heparin nor/~-mercaptoethanol was 
required for functional activity in our system. Our speculation as to a  possible role 
played by heparin in the liver slice assay is that in the absence of heparin, the assay 
is relatively insensitive, the presence of heparin promotes aggregation of CIg-coated 
beads or particles, which in turn lowers the threshold for detection of binding. 
Another consequence of the interaction of monocyte CIgR with CIg-gelatin surfaces 
is the enhanced expression of Fc and C3 receptors (Figs. 8 and 9).  It is tempting to 
suggest that  this phenomenon reflects the ability of CIg to induce monocyte differ- 
entiation to stimulated macrophages such as are found in inflammatory sites.  It will 
be  interesting  to  investigate  whether  these  monocytes  develop  the  capability  of 
secreting neutral proteases such as collagenase, elastase, and plasminogen activator, 
which are able to degrade the same substrates to which they are attached via CIg. 
The observations that  we have made may have relevance for understanding  the 
different behavior of neutrophils and monocytes in the acute inflammatory response. 
During early phases of this reaction, both neutrophils and monocytes migrate to sites 
of injury as a  consequence of their response to chemotactic peptides  generated by 
activation of the complement and coagulation systems  (1),  and  are retained at  the 
injury site as a  result of agents derived from factor B of the alternative pathway of 
complement or from the contact phase of blood coagulation (4). During later phases BEVILACQUA, AMRANI, MOSESSON, AND BIANC:O  57 
of inflammation, macrophages predominate over neutrophils.  This occurrence may 
reflect the disappearance of complement- and coagulation-derived peptides resulting 
in selective retention of those cells bearing CIg receptors. 
Summary 
This  investigation  focused  on  the  role  played  by  cold-insoluble  globulin  (CIg, 
plasma fibronectin) in monocyte function. Surface-bound CIg mediated a concentra- 
tion-dependent attachment of human blood monocytes to gelatin-coated surfaces. CIg 
also mediated the binding of gelatin-coated particles such as latex beads or tanned 
erythrocytes  to  surface-bound  human  monocytes.  However,  CIg  did  not  mediate 
particle ingestion. 
Subfractionated  CIg that  was highly enriched  in  monomeric forms (zone II CIg, 
mol wt  190,000-235,000)  was less effective than  were fractions enriched  in  dimeric 
forms (zone I CIg, mol wt 450,000)  in promoting monocyte attachment.  Binding of 
CIg to a  gelatin  or plastic surface occurred  in  the absence of divalent  cations,  but 
monocyte attachment  to CIg-coated surfaces required  divalent cations, Mg  ++ being 
much more effective than Ca  ++ . Cation-dependent  cell attachment was reversible in 
that bound cells could be released by treatment with EDTA. Serum-mediated binding 
of monocytes to gelatin-coated plastic dishes was a result of its content of CIg because 
the  binding  activity  was  abolished  by  removal of CIg from  serum,  and  could  be 
restored by readdition of purified CIg. Treatment of monocytes with trypsin abolished 
subsequent cell attachment to CIg-gelatin surfaces or particles. Expression of certain 
other known monocyte membrane receptors (Fc and C3b) was markedly enhanced as 
a  result of CIg-monocyte interaction. These several observations indicate that mono- 
cytes bear membrane receptors (termed receptor cold-insoluble globulin)  for surface- 
bound CIg. 
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